Cargando…

HCV entry receptors as potential targets for siRNA-based inhibition of HCV

BACKGROUND: Hepatitis C virus (HCV) is a major health concern with almost 3% of the world's population (350 million individuals) and 10% of the Pakistani population chronically infected with this viral pathogen. The current therapy of interferon-α and ribavirin against HCV has limited efficienc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahan, Shah, Samreen, Baila, Khaliq, Saba, Ijaz, Bushra, Khan, Mahwish, Siddique, Muhammad Hassan, Ahmad, Waqar, Hassan, Sajida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179693/ https://www.ncbi.nlm.nih.gov/pubmed/21896165 http://dx.doi.org/10.1186/1479-0556-9-15

Ejemplares similares

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs
por: Khaliq, Saba, et al.
Publicado: (2010)

Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis
por: Jahan, Shah, et al.
Publicado: (2011)

Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line
por: Jahan, Shah, et al.
Publicado: (2011)

Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs
por: Khaliq, Saba, et al.
Publicado: (2011)

A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation
por: Ahmad, Waqar, et al.
Publicado: (2011)

A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI)
por: Ahmad, Waqar, et al.
Publicado: (2011)

Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
por: Ahmad, Waqar, et al.
Publicado: (2012)

Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation
por: Ahmad, Waqar, et al.
Publicado: (2011)

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
por: Sarwar, Muhammad T, et al.
Publicado: (2011)

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
por: Ahmad, Waqar, et al.
Publicado: (2011)

Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell
por: Asad, Sultan, et al.
Publicado: (2012)

HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers
por: Ijaz, Bushra, et al.
Publicado: (2019)

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Consensus siRNA for inhibition of HCV genotype-4 replication
por: Zekri, Abdel Rahman N, et al.
Publicado: (2009)

Association of laboratory parameters with viral factors in patients with hepatitis C
por: Ijaz, Bushra, et al.
Publicado: (2011)

Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Generation of fluorescent HCV pseudoparticles to study early viral entry events- involvement of Rab1a in HCV entry
por: Bhattacharjee, Chayan, et al.
Publicado: (2022)

Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV
por: Khan, Najib U, et al.
Publicado: (2011)

Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)

Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers
por: Ijaz, Bushra, et al.
Publicado: (2011)

Predictive factors for acquiring HCV infection in the population residing in high endemic, resource-limited settings
por: Khan, Samreen, et al.
Publicado: (2021)

SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment
por: Aslam, Rabia, et al.
Publicado: (2016)

Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa
por: Ali, Ijaz, et al.
Publicado: (2011)

HCV and drug addiction in the historical scenario of infection entry in Italy
por: Massimo, Galli, et al.
Publicado: (2018)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
por: Ali, Amjad, et al.
Publicado: (2011)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development
por: Idrees, Sobia, et al.
Publicado: (2013)

Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan
por: Patoli, Bushra B, et al.
Publicado: (2018)

Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
por: Adnan, Faisal, et al.
Publicado: (2020)

Development of global consensus sequence of HCV glycoproteins involved in viral entry
por: Idrees, Sobia, et al.
Publicado: (2013)

Combinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV Replication
por: Mandal, Anirban, et al.
Publicado: (2016)

Heterogeneous distribution of HCV genotypes and growing menace of mixed HCV infection in blood recipients in Khyber Pakhtunkhwa
por: Attaullah, Sobia, et al.
Publicado: (2017)

HCV and lichen planus: HCV and lichen planus
por: Rebora, Alfredo
Publicado: (2011)

Molecular epidemiology of hcv among health care workers of khyber pakhtunkhwa
por: Khan, Sanaullah, et al.
Publicado: (2011)

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs
por: Hope, Vivian D, et al.
Publicado: (2018)

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
por: Wang, Yizhong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tr0cm4togrk44647cehe1c2rs0